Related references
Note: Only part of the references are listed.Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period
N. Kohei et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Rituximab-induced direct inhibition of T-cell activation
Dina Stroopinsky et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations
Deepa Jagadeesh et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
Ralf Trappe et al.
LANCET ONCOLOGY (2012)
Preserving the B-Cell Compartment Favors Operational Tolerance in Human Renal Transplantation
Hernandez M. Silva et al.
MOLECULAR MEDICINE (2012)
Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy
Christian Morath et al.
TRANSPLANT INTERNATIONAL (2012)
A Randomized, Double-Blind, Placebo-Controlled Study of Single Dose Rituximab as Induction in Renal Transplantation: A 3-Year Follow-Up
Gunnar Tyden et al.
TRANSPLANTATION (2012)
ABO-Incompatible Kidney Transplantation Enabled by Non-Antigen-Specific Immunoadsorption
Christian Morath et al.
TRANSPLANTATION (2012)
The Efficacy and Safety of High-Dose Mizoribine in ABO-Incompatible Kidney Transplantation Using Anti-CD20 and Anti-CD25 Antibody Without Splenectomy Treatment
N. Yoshimura et al.
TRANSPLANTATION PROCEEDINGS (2012)
Excellent Outcomes of ABO-Incompatible Kidney Transplantation: A Single-Center Experience
J. Uchida et al.
TRANSPLANTATION PROCEEDINGS (2012)
Monitoring Infection with Epstein-Barr Virus among Seromismatch Adult Renal Transplant Recipients
S. I. Martin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Successful ABO-Incompatible Kidney Transplantation with Antibody Removal and Standard Immunosuppression
S. M. Flint et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Rituximab in the treatment of acute cellular rejection of renal allograft with CD20-positive clusters in the infiltrate
Jorge Vega et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin
Joseph Kahwaji et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience
Hiroki Shirakawa et al.
CLINICAL TRANSPLANTATION (2011)
The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation
Helena Genberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Increase of infectious complications in ABO-incompatible kidney transplant recipients-a single centre experience
Antje Habicht et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Comparison of Clinical Outcome between High and Low Baseline Anti-ABO Antibody Titers in ABO-Incompatible Kidney Transplantation
Byung Ha Chung et al.
RENAL FAILURE (2011)
Antibody Removal Before ABO-Incompatible Renal Transplantation: How Much Plasma Exchange Is Therapeutic?
Christopher Lawrence et al.
TRANSPLANTATION (2011)
The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab Induction
Shohei Fuchinoue et al.
TRANSPLANTATION (2011)
Pathophysiologic Significance of B-Cell Clusters in Chronically Rejected Grafts
Olivier Thaunat
TRANSPLANTATION (2011)
Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients
N. Kamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Rituximab May Not Lead to Increased Infection Rates in Transplant Recipients
M. Drage et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro
Jean-David Bouaziz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Post-transplant lymphoproliferative disorder following renal transplantation: A single-center experience over 40 years
Toyofumi Abe et al.
INTERNATIONAL JOURNAL OF UROLOGY (2010)
Identification of a B cell signature associated with renal transplant tolerance in humans
Kenneth A. Newell et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era
Andrew M. Evens et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype
Annaick Pallier et al.
KIDNEY INTERNATIONAL (2010)
Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression
Madeleine V. Pahl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis
Jochen Wilpert et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Late-Onset Neutropenia After Rituximab Treatment Case Series and Comprehensive Review of the Literature
Ofir Wolach et al.
MEDICINE (2010)
Antigen-Specific B Cells Reactivate an Effective Cytotoxic T Cell Response against Phagocytosed Salmonella through Cross-Presentation
Jelle de Wit et al.
PLOS ONE (2010)
Evaluation of Low-Dose Rituximab Induction Therapy in Living Related Kidney Transplantation
Toshio Takagi et al.
TRANSPLANTATION (2010)
Incidence of Infectious Complications in Highly Sensitized Renal Transplant Recipients Treated by Rituximab: A Case-Controlled Study
Anne Scemla et al.
TRANSPLANTATION (2010)
Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study
Alexandre Loupy et al.
TRANSPLANTATION (2010)
Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
Ashley A. Vo et al.
TRANSPLANTATION (2010)
Treatment of Acute Antibody-Mediated Rejection: A Single-Center Experience
M. Rodriguez Ferrero et al.
TRANSPLANTATION PROCEEDINGS (2010)
Rituximab-associated acute thrombocytopenia: An under-diagnosed phenomenon
Ron Ram et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Incidence of JC-Virus Replication After Rituximab Therapy in Solid-Organ Transplant Patients
N. Kamara et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
C. Lefaucheur et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution
Jan Gossmann et al.
CLINICAL TRANSPLANTATION (2009)
Impact of rituximab therapy for treatment of acute humoral rejection
Z. Kaposztas et al.
CLINICAL TRANSPLANTATION (2009)
Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection
Edward Shelton et al.
NEPHROLOGY (2009)
ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies
Tobias Oettl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
B-Cell-Depleting Induction Therapy and Acute Cellular Rejection
Menna R. Clatworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient
D. Kumar et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy
Hayato Nishida et al.
TRANSPLANT INTERNATIONAL (2009)
Treatment of symptomatic transplant glomerulopathy with rituximab
Lionel Rostaing et al.
TRANSPLANT INTERNATIONAL (2009)
ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad Implementation
Robert A. Montgomery et al.
TRANSPLANTATION (2009)
Rituximab for Humoral Rejection After Kidney Transplantation: An Update
Lionel Rostaing et al.
TRANSPLANTATION (2009)
A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation
Gunnar Tyden et al.
TRANSPLANTATION (2009)
A Single Low-Fixed Dose of Rituximab to Salvage Renal Transplants From Refractory Antibody-Mediated Rejection
William R. Mulley et al.
TRANSPLANTATION (2009)
Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
Thomas Fehr et al.
TRANSPLANTATION (2009)
Diagnosis and Treatment of Acute Humoral Kidney Allograft Rejection
A. M. Gomes et al.
TRANSPLANTATION PROCEEDINGS (2009)
Vienna experience of ABO-incompatible living-donor kidney transplantation
Michael Haidinger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2009)
A Randomized, Prospective Trial of Rituximab for Acute Rejection in Pediatric Renal Transplantation
V. Zarkhin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Rituximab and intravenous immune globulin for desensitization during renal transplantation
Ashley A. Vo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
ABO Incompatible Living Renal Transplantation With a Steroid Sparing Protocol
Jack Galliford et al.
TRANSPLANTATION (2008)
Renal transplantation in patients with positive lymphocytotoxicity crossmatches: One center's experience
Colm C. Magee et al.
TRANSPLANTATION (2008)
Successful Treatment of Chronic Antibody-Mediated Rejection With IVIG and Rituximab in Pediatric Renal Transplant Recipients
Heiko Billing et al.
TRANSPLANTATION (2008)
ABO Blood Type Incompatible Kidney Transplantation Without Splenectomy Prepared With Plasma Exchange and Rituximab
T. Chikaraishi et al.
TRANSPLANTATION PROCEEDINGS (2008)
Successful therapy with rituximab of refractory acute humoral renal transplant rejection: A case report
A. Celik et al.
TRANSPLANTATION PROCEEDINGS (2008)
Rituximab in highly sensitized kidney transplant recipients
A. S. Munoz et al.
TRANSPLANTATION PROCEEDINGS (2008)
High-Dose Intravenous Immunoglobulin and Rituximab Treatment for Antibody-Mediated Rejection After Kidney Transplantation: A Cost Analysis
B. Tanriover et al.
TRANSPLANTATION PROCEEDINGS (2008)
Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: A case report
G. T. Moscoso-Solorzano et al.
TRANSPLANTATION PROCEEDINGS (2007)
Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection
Oliver M. Steinmetz et al.
TRANSPLANTATION (2007)
On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation
Jochen Wilpert et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients
Shellee A. Grim et al.
CLINICAL TRANSPLANTATION (2007)
Rituximab therapy for acute humoral rejection after kidney transplantation
Stanislas Faguer et al.
TRANSPLANTATION (2007)
Drug Insight: the mechanism of action of rituximab in autoimmune disease - the immune complex decoy hypothesis
Ronald P. Taylor et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French Registry
S. Caillard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Posttransplant lymphoproliferative disease:: A series of 23 cases
M. A. Martin-Gomez et al.
TRANSPLANTATION PROCEEDINGS (2006)
Pharmacodynamics of rituximab in kidney allotransplantation
H. Genberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab
J Svoboda et al.
TRANSPLANT INTERNATIONAL (2006)
Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab
A Lehnhardt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy
K Saito et al.
XENOTRANSPLANTATION (2006)
A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation
JM Gloor et al.
TRANSPLANTATION (2005)
Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation
N Mitsuhata et al.
TRANSPLANTATION (2005)
Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab
M Alausa et al.
CLINICAL TRANSPLANTATION (2005)
Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy
CJ Sonnenday et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Rituximab as treatment for refractory kidney transplant rejection
YT Becker et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab
G Tydén et al.
TRANSPLANTATION (2003)
Overcoming a positive crossmatch in living-donor kidney transplantation
JM Gloor et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Successful Al-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis
T Sawada et al.
TRANSPLANTATION (2002)
Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.
F Suzan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
